Cargando…

Treatment of canine generalized demodicosis associated with hyperadrenocorticism with spot-on moxidectin and imidacloprid

BACKGROUND: Canine generalized demodicosis associated with hyperadrenocorticism is often problematic and might be intractable. The aim of this study was to report the efficacy of a weekly application of spot-on moxidectin/imidacloprid in dogs with hyperadrenocorticism and secondary generalized demod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Hui-Pi, Lien, Yu-Hsin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663785/ https://www.ncbi.nlm.nih.gov/pubmed/23663380 http://dx.doi.org/10.1186/1751-0147-55-40

Ejemplares similares

Efficacy of topically administered fluralaner or imidacloprid/moxidectin on dogs with generalised demodicosis
por: Fourie, Josephus J., et al.
Publicado: (2019)

Efficacy of orally administered fluralaner (Bravecto(TM)) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs
por: Fourie, Josephus J, et al.
Publicado: (2015)

Heat pretreatment of canine samples to evaluate efficacy of imidacloprid + moxidectin and doxycycline in heartworm treatment
por: Bendas, Alexandre José Rodrigues, et al.
Publicado: (2017)

Efficacy of imidacloprid 10%/moxidectin 1% spot-on formulation (Advocate®) in the prevention and treatment of feline aelurostrongylosis
por: Heuer, Lea, et al.
Publicado: (2020)

Efficacy of a combination of imidacloprid 10%/moxidectin 2.5% spot-on (Advocate® for dogs) in the prevention of canine spirocercosis (Spirocerca lupi)
por: Le Sueur, Christophe, et al.
Publicado: (2010)

Efficacy and safety of imidacloprid 10 %/moxidectin 1 % spot-on formulation in the treatment of feline infection by Capillaria aerophila
por: Traversa, Donato, et al.
Publicado: (2012)

Effectiveness of the spot-on combination of moxidectin and imidacloprid (Advocate®) in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected cats
por: Otranto, Domenico, et al.
Publicado: (2019)

Effect of Therapy by Using Advocate Spot-On Combination (Imidacloprid 10% and Moxidectin 2.5%) on Subcutaneous Dirofilariosis in Dogs
por: Paran, Radmila Dobešová, et al.
Publicado: (2011)

Canine demodicosis: Hematological and biochemical alterations
por: Salem, N. Y., et al.
Publicado: (2020)

Associations among systemic blood pressure, microalbuminuria and albuminuria in dogs affected with pituitary- and adrenal-dependent hyperadrenocorticism
por: Lien, Yu-Hsin, et al.
Publicado: (2010)

Assessment of left ventricular function by two-dimensional speckle-tracking echocardiography in small breed dogs with hyperadrenocorticism
por: Chen, Hung-Yin, et al.
Publicado: (2014)

Efficacy of a moxidectin/imidacloprid spot-on formulation (Advocate(®)) for the treatment of Troglostrongylus brevior in naturally infected cats in a field study in Greece
por: Diakou, Anastasia, et al.
Publicado: (2019)

Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis
por: Beugnet, Frédéric, et al.
Publicado: (2016)

Carbenoxolone Disodium Treatment for Canine Pituitary-Dependent Hyperadrenocorticism
por: Teshima, Takahiro, et al.
Publicado: (2016)

Efficacy of oral fluralaner for the treatment of canine generalized demodicosis: a molecular-level confirmation
por: Djuric, Milos, et al.
Publicado: (2019)

Determining resolution of Angiostrongylus vasorum in dogs following anthelmintic treatment with an imidacloprid 10 per cent/moxidectin 2.5 per cent spot-on
por: Bird, Louise Elizabeth, et al.
Publicado: (2018)

Efficacy of a spot-on combination containing 10% w/v imidacloprid and 1% w/v moxidectin for the treatment of troglostrongylosis in experimentally infected cats
por: Traversa, Donato, et al.
Publicado: (2022)

Association of Renal Resistive Index, Renal Pulsatility Index, Systemic Hypertension, and Albuminuria with Survival in Dogs with Pituitary-Dependent Hyperadrenocorticism
por: Chen, Hung-Yin, et al.
Publicado: (2016)

Development of Demodicosis after Omalizumab Injection
por: Park, Sujin, et al.
Publicado: (2023)

First Feline Case of Otodectosis in the Republic of Korea and Successful Treatment with Imidacloprid/Moxidectin Topical Solution
por: Ahn, Ah-Jin, et al.
Publicado: (2013)

Evaluation of a spot-on imidacloprid-moxidectin formulation (Advocate®) for the treatment of naturally occurring esophageal spirocercosis in dogs: a double-blinded, placebo-controlled study
por: Segev, Gilad, et al.
Publicado: (2018)

Clinical assessment of heartworm‐infected Beagles treated with a combination of imidacloprid/moxidectin and doxycycline, or untreated
por: Savadelis, Molly D., et al.
Publicado: (2020)

A European field assessment of the efficacy of fluralaner (Bravecto(®)) chewable and spot-on formulations for treatment of dogs with generalized demodicosis
por: Petersen, Ivo, et al.
Publicado: (2020)

Efficacy of a spot-on formulation containing moxidectin 2.5%/imidacloprid 10% for the treatment of Cercopithifilaria spp. and Onchocerca lupi microfilariae in naturally infected dogs from Portugal
por: Otranto, Domenico, et al.
Publicado: (2021)

Efficacy of Amitraz plus Metaflumizone for the treatment of canine demodicosis associated with Malassezia pachydermatis
por: Tarallo, Viviana D, et al.
Publicado: (2009)

Critically appraised topic for the most effective and safe treatment for canine generalised demodicosis
por: Perego, Roberta, et al.
Publicado: (2019)

Decreased Gene Expressions of Insulin Signal Molecules in Canine Hyperadrenocorticism
por: NOZAWA, Satoshi, et al.
Publicado: (2014)

Antibody Response to Canine Parvovirus Vaccination in Dogs with Hyperadrenocorticism Treated with Trilostane
por: Bergmann, Michèle, et al.
Publicado: (2020)

Patterns of the low‐dose dexamethasone suppression test in canine hyperadrenocorticism revisited
por: Zeugswetter, Florian K., et al.
Publicado: (2021)

Serum Cortisol Concentrations in Dogs with Pituitary‐Dependent Hyperadrenocorticism and Atypical Hyperadrenocorticism
por: Frank, L.A., et al.
Publicado: (2014)

Fluralaner 5.46% (w/w) flavored chewable tablet (Bravecto(®) 1-Month) is effective for treatment of canine generalized demodicosis
por: Rohdich, Nadja, et al.
Publicado: (2022)

Facial Spinulate Demodicosis
por: Zahr Allayali, Ahmed
Publicado: (2021)

Use of a doxycycline-enrofloxacin-metronidazole combination with/without diminazene diaceturate to treat naturally occurring canine babesiosis caused by Babesia gibsoni
por: Lin, Ming-Yu, et al.
Publicado: (2010)

Efficacy of imidacloprid + moxidectin and selamectin topical solutions against the KS1 Ctenocephalides felis flea strain infesting cats
por: Dryden, Michael W, et al.
Publicado: (2011)

Efficacy of a combination of 10% imidacloprid and 1% moxidectin against Caparinia tripilis in African pygmy hedgehog (Atelerix albiventris)
por: Kim, Kyu-Rim, et al.
Publicado: (2012)

Correction to: Fluralaner 5.46% (w/w) favored chewable tablet (Bravecto® 1-Month) is effective for treatment of canine generalized demodicosis
por: Rohdich, Nadja, et al.
Publicado: (2022)

Suspected spontaneous hyperadrenocorticism in a young experimental beagle dog
por: Obara, Ryo D., et al.
Publicado: (2021)

Assessment of parasitological findings in heartworm-infected beagles treated with Advantage Multi® for dogs (10% imidacloprid + 2.5% moxidectin) and doxycycline
por: Savadelis, Molly D., et al.
Publicado: (2017)

Demodicosis as treatment complication of amicrobial pustulosis of the folds
por: Jorge, Marilia Formentini Scotton, et al.
Publicado: (2018)

Effectiveness of a fluralaner spot-on formulation in a case of feline demodicosis due to Demodex cati
por: Bouza-Rapti, Pavlina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iksdr4ro104a3rug92nk66qakc